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malignant lymphomas. Its involvement in the oral cavity has not been reported
previously. We describe the case of a 43 year-old male patient suffering intra-oral
SLL. Microscopic examination of the incisional biopsy specimen revealed a diffuse
and monotonous pattern of small lymphocytes with proliferation centers composed
of prolymphocytes or para-immunoblasts. Immunohistochemical (IHC) staining
demonstrated that these neoplastic lymphoid cells proved to be positive for LCA,
CD5, CD20, CD79a, CD23, CD43, Bcl-2, Bcl-6, and negative for CD10, Bcl-1 (cyclin
D1), CD3, CD30, as well as negative for CD68, and smooth-muscle actin, kappa and
lambda. Based upon the histological features and the IHC assay pattern, a case of
intra-oral SLL and its differential diagnosis using immunohistochemistry is reported
here.c 2004 Elsevier Ltd. All rights reserved.
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Small lymphocytic lymphoma (SLL) is a low-grade
malignant lymphoma characterized morphologi-
cally by a proliferation of small, mature-appearing
lymphocytes.1 From a review of the literature, it
would appear to comprise around 7% of all non-
Hodgkin’s lymphoma cases in all geographic areas2* Corresponding author. Tel.: +886-7-3121121–2292/012292;
fax: +886-7-3210637.
E-mail address: k0285@ms22.hinet.net (L.-M. Lin).
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doi:10.1016/j.ooe.2004.04.001but only 1% of all non-Hodgkin’s lymphomas in
Taiwan.3 Microscopically, SLL shows a close
resemblance to other small B-cell lymphomas such
as mantle-cell lymphoma (MCL), follicular lym-
phoma (FL) and marginal-zone lymphoma (MZL).4
Although SLL is primarily nodal, hepatic and splenic
involvement may arise, and other extranodal tis-
sues such as orbit,5 lung,6 skin7 and stomach8 may
occasionally be involved. To our knowledge, its
occurrence in the oral cavity has not yet been re-
ported. Here, we report on a case of intra-oral SLL
as well as the case’s differential diagnosis using
immunohistochemistry.ved.
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A 43 year-old male patient was referred to our
institution for further examination for the swelling
of left face by a local dental clinic. Extra-oral
examination revealed a painful swelling of the left
cheek (Fig. 1A) whereas intra-oral examination
demonstrated an ulceration, measuring about 1 · 1
cm in diameter, located over the left tuberosity
and a painful swelling over the left buccal mucosa
(Fig. 1B). Periapical radiography revealed an
inconspicuous poorly defined radiolucence over the
distal aspect of tooth 25 (Fig. 1C). Computerized
tomography (CT) demonstrated massive soft-tissue
lesions involving multiple tissue spaces and leading
to the bony destruction of the maxilla, the wall of
the maxillary sinuses and the mandibular ramus
(Fig. 1D). Bilateral submandibular lymph-node
involvement was suspected upon CT (Fig. 1E). No
systemic symptoms such as fever, weight loss, or
night sweats were reported, and no abdominal
masses or tenderness, ascites, or hepatospleno-
megaly were noted. A chest scan appeared to be
normal. A peripheral blood smear revealed a
normal white blood cell count. A bone-marrowFigure 1 (A) A painful swelling was noted over the patie
tuberosity (black arrow) and a painful, tender swelling over t
(C) Periapical radiography revealed an apical lesion over res
poorly defined radiolucence was found over the distal aspect
(CT) revealing extensive soft-tissue lesions involving the lef
fossa, oropharyngeal space, palate, parapharyngeal space and
the maxilla, the wall of the maxillary sinuses and the mand
involvement was suspected upon CT scan investigation.aspiration demonstrated normal cellularity (43%)
with an adequate level of megakaryocytes being
noted to be present. Both myeloid (M) and ery-
throid (E) studies revealed normal maturation and
differentiation with an M/E ratio of 3.6:1, there
appearing to be no evidence of absolute lympho-
cytosis.
Incisional biopsies over the palatal and buccal
lesions were then performed under local anesthe-
sia. Microscopically, both specimens were chiefly
composed of monotonous small lymphocytes,
revealing a mature-appearance with clumped
chromatin and slightly angulated nuclei (Fig. 2A).
Under high-power, a few lymphoid cells featuring
scanty cytoplasm were noted (Fig. 2A, inset a).
Some neoplastic lymphoid cells exhibiting a rather
pleomorphic appearance and demonstrating evi-
dence of abnormal mitosis (Fig. 2A, inset b) were
also occasionally noted. In addition, some larger,
paler cells consistent with prolymphocytes could
be seen (Fig. 2A, inset c), and in certain areas,
a diffuse proliferation of small lymphoid cells with
the preservation of a sinus was apparent (Fig. 2B).
Significantly, we noted pale-staining areas of
pseudofollicles (Fig. 2C) containing large palernt’s left cheek (arrow). (B) An ulceration over the left
he left buccal mucosa (green arrows) were also observed.
idual root of tooth 25 (yellow arrow). An inconspicuous
of tooth 25 (red arrows). (D) Computerized tomography
t nasopharyngeal space, maxillary sinus, infra-temporal
the buccal space and resulting in the bony destruction of
ibular ramus (arrows). (E) Bilateral submandibular nodal
Figure 2 (A) The neoplastic lymphocytic infiltrates for both palatal and buccal specimens were chiefly composed of
monotonous small, mature-appearance lymphocytes with clumped chromatin and slightly angulated nuclei upon low-
power view (H-E stain· 40). A few lymphoid cells featuring scanty cytoplasm may also be noted (inset a, green arrows,
H-E stain · 400). Some neoplastic lymphoid cells revealing a pleomorphic appearance, and demonstrating abnormal
mitosis (inset b, red arrows, H-E stain · 400) may also be noted. Some larger, paler cells consistent with prolympho-
cytes may be seen (inset c, blue arrows, H-E stain· 400). (B) A diffuse proliferation of small lymphoid cells with
preservation of sinus (S) is clearly apparent (H-E stain · 100). (C) Pale-staining areas of pseudofollicles containing large
even paler cells (H-E stain · 100) containing oval nuclei, dispersed chromatin and a prominent nucleolus compatible
with para-immunoblasts (inset, H-E stain · 400) may be noted.
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chromatin and a prominent nucleolus compatible
with para-immunoblasts (Fig. 2C, inset). These
histological features raised the possibility of the
present lesion being one variant of a family of low-
grade B-cell neoplasm specific possibilities includ-
ing SLL, MCL, FL and MZL.
Immunohistochemical staining (IHS) with various
antibodies was then performed (Table 1). In sum-
mary, these neoplastic lymphoid cells were posi-
tive for LCA, CD5 (Fig. 3A), CD20 (Fig. 3C), CD79a,
CD23 (Fig. 3D), CD43 (Fig. 3E), Bcl-2 (Fig. 3G), Bcl-6
(Fig. 3H), and were negative for CD10 (Fig. 3B),
Bcl-1 (cyclin D1) (Fig. 3F), CD3, CD30 (Fig. 3I), as
well as negative for CD68, smooth-muscle actin,
kappa and lambda. Based upon these IHS results
[CD5 (+), CD20 (+), CD23 (+), CD43 (+), Bcl-1 ())
and Bcl-2 (+)], a histological diagnosis of SLL was
rendered. He refused to undergo any further
treatment and was lost to follow-up. About 1 year
later, the patient reappeared at our out-patient
clinic to apply for the official pathological report.
At this time, this patient’s condition appeared to
be stable following the completion of chemother-apy, which was performed in another teaching
hospital in Northern Taiwan; however, the detailed
treatment regimen for this was not able to be
discerned.Discussion
SLL is chiefly a disease of middle age and the
elderly, with a median age at diagnosis of 55–61
years and very few SLL patients who are less than
40 years old.9 The male-to-female ratio for SLL is
approximately 2:1.10 Our case was broadly consis-
tent with those cases of SLL previously reported in
the literature.9;10
To our knowledge, the clinical details of and
prognosis for SLL in the oral cavity are not com-
pletely known. The modified Ann Arbor system11
for cancer staging suggests that: stage I SLL indi-
cates the involvement of some lymphoid structures
or possibly a lymph-node region, whereas stage II
exhibits the involvement of two or more lymph-
node regions on the same side of the diaphragm;
stage III disease denotes the involvement of
Table 1 Antibodies used for tissue identification, their predominant reactivity and results
Antibodies Sources (dilution) Predominant reactivity Results
CD45 Dako (1:200) Leukocyte common antigen +
CD20 Dako (1:100) Pan B-cell +
CD79a Dako (1:100) Pan B-cell +
CD10 Novocastra (1:80) B-cell and granulocyte )
CD5 Novocastra (1:80) Pan T-cell and some B-cell lymphomas +
CD23 Dako (1:200) B-cell and dendritic cells +
CD43 Novocastra (1:80) T-cell and B-cell subset +
CD3 Dako (1:200) Pan T-cell )
CD68 Dako (1:200) Macrophage )
Anti-kappa Dako (1:200) Kappa light chain )
Anti-lambda Dako (1:200) Lambda light chain )
Smooth-muscle actin Chemical International (1:50) Actin protein )
S-100 Dako (1:200) S-100 protein )
Bcl-1 (cyclin D1) Novocastra (1:80) Cyclin D1 protein )
Bcl-2 Novocastra (1:80) Anti-apoptotic death protein +
Bcl-6 Novocastra (1:30) Bcl-6 putative transcription factor +
Figure 3 The neoplastic lymphoid cells proved to be positive for CD5 (A); CD20 (C); CD23 (D); CD43 (E); Bcl-2 (G); Bcl-
6 (H), and negative for CD10 (B); Bcl-1 (cyclin D1) (F); CD30 (I) (·100).
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the diaphragm, whilst stage IV disease is repre-
sented by the diffuse, disseminated involvement of
one or more extralymphatic organs, such as bone
marrow, liver, or lung. Our patient appeared to
suffer stage III SLL at initial presentation when
classified with respect to the modified Ann Arbor
system. The patient appeared to have experienceda good response to chemotherapy, however, long-
term follow-up, which is necessary to determine
the disease’s entire course, was not available, but
its conduct is strongly cautioned for all such cases.
Microscopically, both morphological and IHC
findings of the neoplastic lymphoid cells of the
present case share a close resemblance to those
cases of SLL occurring in lymph nodes and extran-
Intra-oral small lymphocytic lymphoma 77odal sites.1 The primary differential diagnoses of
the current case comprise other small B-cell lym-
phomas including FL, MZL, and particularly MCL.
Histologically, MCL is characterized by a mono-
morphic lymphocytic infiltrate with a diffuse, va-
guely nodular, or expanded mantle-zone pattern;
the neoplastic lymphoid cells are small to medium,
with nuclear contours ranging from slightly to
markedly irregular.12 Therefore, it appears clear
that such a morphological picture shares some
resemblance to the present case (SLL) and the
distinction between these two entities, using
morphological features alone, is frequently chal-
lenging and remains important because MCL has
been recognized as a clinically aggressive lym-
phoma for which a modified treatment needs to be
adopted accordingly.2
Immunophenotypically, the neoplastic lymphoid
cells for MCL are usually CD5 (+), CD20 (+), and
CD43 (+), Bcl-2 (+), but CD10 ()) or Bcl-6 ()).12 The
lymphocytic infiltrates are typically CD23 ()), but
occasionally, they may be weakly positive.12 Typi-
cally, all lymphocytic specimens are Bcl-1 (+), al-
though for the rare specimen, the evidence may
suggest CD5 ()).13 This IHC pattern is very similar
to that noted for SLL, i.e. [CD5 (+), CD20 (+), CD23
(+), CD43 ()), Bcl-1 ()) and Bcl-2 (+)],1 such that
Bcl-1 staining is very important to discriminate
between MCL and SLL.1 The IHC pattern revealed
for the present case conformed fully to the criteria
for a case of SLL.
For a typical case of FL, a nodular (follicular)
pattern is usually observed with neoplastic lym-
phoid cells typically reflecting CD10 (+), CD20 (+),
and Bcl-2 (+); CD5 ()), CD43 ()), Bcl-1 ()) and CD23
()) [but occasionally CD23 (+)].4 No nodular pat-
tern of detected lymphoid cells appeared to have
been expressed for the current case. In addition,
an overt different IHC pattern was noted for this
case [CD5 (+), CD43 (+) and CD10 ()), CD23 ())]
when compared to analogous results of typical
cases of FC. MZL usually expresses an expanded
marginal-zone pattern and contains a cascade of
heterogeneous neoplastic lymphoid cells including
centrocyte-like small cells, monocytoid lympho-
cytes, large transformed lymphocytes, plasmacy-
toid lymphocytes, and plasma cells.4 Such
histological features were obviously not demon-
strated for the current case. The neoplastic lym-
phocytes typical of cases of MZL are usually CD20
(+); frequently Bcl-2 (+); occasionally CD43 (+); and
CD5 ()), Bcl-1 ()), CD10 ()) and CD23 ()), thus, the
IHC pattern revealed by this case was not indica-
tive of cases of MZL.
For a palatal lymphoid lesion, the extranodal
NK/T-cell lymphoma (nasal type) should also beincluded in the suite of potential diagnoses, as it is
the most-common lymphoma involving the sino-
nasal region and hard palate.14 This type of lym-
phoma is characterized by lymphocytic infiltrate
revealing angiocentric invasion, prominent necrosis
and vascular destruction as well as expressing
markers for NK-cells (CD56) or T-cells (CD3), but
not those of B-cells (CD20 and CD79a).15 For the
present case, the histological characteristics of
angiocentricity, necrosis and vessel destruction
were not observed, and furthermore, our case re-
vealed positive staining for B-cell markers and
negative staining for T-cell markers.
There has been a systemic counterpart of SLL
reported previously, namely, chronic lymphocytic
leukemia (CLL).1 Discrimination between SLL and
CLL may be difficult, and, typically, is based upon a
blood examination; absolute lymphocytosis is
indicative of involvement by CLL.1 For this patient,
no marrow and blood infiltration by neoplastic
lymphoid cells was detected; therefore, a rather
good prognosis would likely be able to be pre-
dicted.
Both SLL and CLL may be associated with second
lymphoid malignant neoplasms, which may occur
simultaneously or present up to 20 years later.16
Approximately 3–10% of patients featuring CLL
progress to cases of diffuse large B-cell lymphoma
(so-called Richter’s transformation).16 Hodgkin’s
disease also may occur simultaneously or develop
subsequently for CLL patients (a transformation
called ‘Hodgkin’s disease variant of Richter’s syn-
drome’).17 For the present patient, there was no
evidence of Hodgkin’s disease because neither
Reed-Sternberg-like cells nor CD30-stained cells
were able to be detected.Acknowledgements
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